Buy & Sell Mesoblast Limited (MESO) – Mesoblast Limited Price Today
Key Stats
- $2.08BMarket Cap
- TechnologySector
- -28.59%3M Drawdown
- $2.08BEnterprise Value
- -Dividend Yield
Mesoblast Limited (MESO) is currently valued at a market capitalization of $2.08B, with an enterprise value of $2.08B. Over the past 52 weeks, Mesoblast Limited has traded between a low of $10.16 and a high of $20.96, highlighting its annual price range. Over the past three months, Mesoblast Limited has recorded a drawdown of -28.59%, reflecting recent price volatility.
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
